Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Five series of Src tyrosine kinase inhibitors reported by AstraZeneca

Feb. 15, 2005

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Feb. 15, 2005

Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature

Feb. 14, 2005

Novel antiinflammatory chalcones patented by AtheroGenics

Feb. 14, 2005

Bristol-Myers Squibb patent covers new antiinflammatory agents

Feb. 14, 2005

Aventis imparts new tubulin polymerization inhibitors for cancer therapy

Feb. 14, 2005

New anticoagulant agents reported by Bristol-Myers Squibb

Feb. 14, 2005

Three series of chemokine CCR4 receptor modulators claimed by AstraZeneca

Feb. 14, 2005

Novel PARP-1 inhibitors described by Altana Pharma in recent patent

Feb. 11, 2005

Novel protein tyrosine kinase inhibitors and their use as anticancer agents

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...